• KGS/USD = 0.01149 0.87%
  • KZT/USD = 0.00201 0%
  • TJS/USD = 0.09176 0.33%
  • UZS/USD = 0.00008 0%
  • TMT/USD = 0.28573 -0.14%
  • KGS/USD = 0.01149 0.87%
  • KZT/USD = 0.00201 0%
  • TJS/USD = 0.09176 0.33%
  • UZS/USD = 0.00008 0%
  • TMT/USD = 0.28573 -0.14%
  • KGS/USD = 0.01149 0.87%
  • KZT/USD = 0.00201 0%
  • TJS/USD = 0.09176 0.33%
  • UZS/USD = 0.00008 0%
  • TMT/USD = 0.28573 -0.14%
  • KGS/USD = 0.01149 0.87%
  • KZT/USD = 0.00201 0%
  • TJS/USD = 0.09176 0.33%
  • UZS/USD = 0.00008 0%
  • TMT/USD = 0.28573 -0.14%
  • KGS/USD = 0.01149 0.87%
  • KZT/USD = 0.00201 0%
  • TJS/USD = 0.09176 0.33%
  • UZS/USD = 0.00008 0%
  • TMT/USD = 0.28573 -0.14%
  • KGS/USD = 0.01149 0.87%
  • KZT/USD = 0.00201 0%
  • TJS/USD = 0.09176 0.33%
  • UZS/USD = 0.00008 0%
  • TMT/USD = 0.28573 -0.14%
  • KGS/USD = 0.01149 0.87%
  • KZT/USD = 0.00201 0%
  • TJS/USD = 0.09176 0.33%
  • UZS/USD = 0.00008 0%
  • TMT/USD = 0.28573 -0.14%
  • KGS/USD = 0.01149 0.87%
  • KZT/USD = 0.00201 0%
  • TJS/USD = 0.09176 0.33%
  • UZS/USD = 0.00008 0%
  • TMT/USD = 0.28573 -0.14%

Viewing results 1 - 6 of 203

Tajikistan’s Health Ministry Seeks Alternative to USAID Assistance in Combating Deadly Diseases

Tajikistan’s Ministry of Health is exploring alternative funding sources following the suspension of USAID programs. The recent freeze on U.S. foreign aid has affected several health initiatives in Tajikistan, particularly those focused on combating HIV/AIDS, tuberculosis, and malaria. At a press conference, Health Minister Jamoliddin Abdullozoda stated that authorities are seeking new mechanisms to sustain these programs. “USAID has played a key role in the fight against HIV, tuberculosis, malaria, as well as in maternal and child health. Until the agency’s future involvement is clarified, we intend to mobilize other resources,” Abdullozoda said. One of Tajikistan’s main partners remains the Global Fund to Fight AIDS, Tuberculosis, and Malaria, which continues to finance drug supplies and testing. The Health Ministry confirmed its commitment to strengthening cooperation with the Fund and engaging additional international organizations. Tajikistan's Republican Center for AIDS Prevention and Control clarified that USAID did not provide antiretroviral therapy (ARV) drugs or testing kits. Instead, the agency’s primary role was offering psychological and social support to HIV patients, mainly through nongovernmental organizations. According to official data, 12,480 people living with HIV are currently registered in Tajikistan’s healthcare system, including 1,022 children. In 2023, 293 new cases were detected among labor migrants. However, the overall number of registered HIV cases declined by 98 compared to previous years. Regarding tuberculosis, Tajikistan recorded 4,545 new cases in 2023 and 4,537 in 2024. The health minister attributed the slight increase to improved diagnostic capabilities. The country now has 77 tuberculosis diagnostic machines, 84 BAG laboratories, and 40 specialized devices for detecting infections.

Criticism of Kazakhstan’s Health Insurance System Reaches Parliament

Members of Kazakhstan's Mazhilis (lower house of parliament) have voiced strong criticism of the country’s healthcare system, particularly the Social Health Insurance Fund, which they argue has lost public trust. Many citizens reportedly view the quality of medical services as unsatisfactory. Kazakhstan operates a system of compulsory social medical insurance, wherein doctors' services are funded through a combination of contributions from working citizens, their employers, and the state budget. These financial contributions are collected by the Social Health Insurance Fund, which then allocates the funds to medical institutions based on the volume of services provided to the population. Speaking in Parliament, Health Minister Akmaral Alnazarova defended the system, claiming that it has led to improvements in key health and demographic indicators since its introduction. “Today, 83% of Kazakhstanis are connected to the compulsory social health insurance system, 72% of whom are from vulnerable segments of the population. This demonstrates the availability of medical care in the country,” Alnazarova stated. However, Mazhilis Deputy Chairman Dania Yespayeva pointed out that despite increasing healthcare budgets, public satisfaction with medical services continues to decline. According to surveys, up to 47% of Kazakhstanis consider the quality of domestic healthcare to be poor. Deputy Askhat Aimagambetov echoed these concerns, accusing medical institutions of manipulating service statistics to secure additional funding from the Social Health Insurance Fund. He cited a case where a five-month-old child, who had not yet developed teeth, was recorded as having received dental services. Aimagambetov also claimed that hospitals sometimes charge the insurance fund for dozens of services provided to the same patient in a single day - an impossibility. “The financing system encourages such behavior because payments are based on the quantity of services rendered, not on the effectiveness of treatment. As a result, the [Social Health Insurance Fund] has become a de facto bank for the Ministry of Health. Citizens and doctors alike have become hostages of inconsistent and poorly planned reforms, while the availability and quality of care have deteriorated. The system remains underfunded, and the resources it does have are spent inefficiently,” Aimagambetov stated. He emphasized the need for stricter oversight of the reports submitted by medical institutions to the insurance fund for reimbursement. Currently, inspections cover only about 1% of these reports, a figure Aimagambetov described as insufficient. Public dissatisfaction with health care is also reflected in broader trends. As previously reported by The Times of Central Asia, approximately 5% of Kazakhstanis considering emigration cite access to better medical services abroad as a primary reason.

Kindergarten in Uzbekistan Stages Dangerous Show with Poisonous Cobras

A kindergarten in Uzbekistan sparked widespread outrage after staging a performance involving poisonous Central Asian cobras, a species listed in the Red Book of Uzbekistan's endangered plant and animals. Footage of the event, which was shared on social media, showed the snakes being handled in close proximity to children, raising serious concerns about safety and animal welfare. In the video, a man can be seen demonstrating two venomous snakes to a group of young children, with no apparent safety measures in place. The cobras were allowed to move freely on the floor near the children. The Uzbek language heard in the recording confirms the location as Uzbekistan, but the exact location of the kindergarten has yet to be identified. The incident has prompted public outcry, with many questioning the judgment of the organizers and the lack of safeguards for the children. So far, the Ministry of Preschool and School Education has refrained from issuing an official statement. The situation has caught the attention of the Children's Ombudsman in Uzbekistan. The Ombudsman’s press service announced that law enforcement agencies are actively working to determine the circumstances and location of the performance, as well as the identities of those responsible. A full investigation is underway, and the organizers’ actions will be subject to legal assessment once the inquiry is complete. This is not the first time unauthorized animal performances have taken place in Uzbekistan. In December of last year, a similar case was reported in the Koshrabad district of the Samarkand region. Two individuals held unauthorized shows at schools and kindergartens, featuring a tiger python. The snake was later confiscated and handed over to the regional department of ecology. These incidents highlight a recurring issue of unregulated animal performance in educational institutions, raising questions about safety, legal oversight, and the ethical treatment of wildlife.

Kyrgyzstan Gears Toward Self-Sufficiency in Medication

Kyrgyzstan has taken a significant step toward reducing its dependence on imported pharmaceuticals with the launch of domestic medicine production at the Aidan Pharma pharmaceutical plant. The facility has begun manufacturing its first batch of essential medications, including: Paracetamol (suspensions and tablets); Ibuprofen (suspensions); Acetylsalicylic acid (tablets); and Acyclovir (tablets). The plant has the capacity to produce up to 10,000 packages of each of these medicines per day, offering an important boost to the country’s pharmaceutical industry. In late 2023, Aidan Pharma began producing medical ethyl alcohol, which is now supplied to state hospitals and pharmacies. During a visit to the plant on January 10, Health Minister Alymkadyr Beishenaliev announced plans to expand the plant’s product range to 100 items by the end of this year. He also revealed that the company intends to begin exporting its products in the future. “The plant's products meet quality standards and have a low production cost, making them more affordable compared to imported medicines,” Beishenaliev noted. The Kyrgyz government has prioritized reducing the country’s reliance on imported medications. In December 2024, the Cabinet of Ministers approved an investment agreement for a Kyrgyz-Chinese pharmaceutical project led by Standard Pharm Group. This initiative will focus on packaging pharmaceuticals and constructing a new pharmaceutical plant in Kyrgyzstan. The project, which will be implemented in two stages over five years, is expected to attract over $41 million in investment. According to Minister of Economy and Commerce Bakyt Sydykov, the plant will manufacture a range of medicines, including: Nutritional infusions; Antibacterial, anti-inflammatory, and antipyretic medications; Analgesics; Hypoglycemic treatments; and Gastrointestinal drugs. Most of these medicines are included in Kyrgyzstan’s List of Vital Medicines, a critical inventory of essential pharmaceuticals that are currently not produced domestically. The development of Kyrgyzstan’s pharmaceutical industry marks a critical shift toward self-sufficiency in healthcare. By expanding domestic production, the government aims to make essential medications more accessible and affordable for its population while fostering economic growth through investment and exports.

Kazakhstan Will Not Impose Quarantine for Metapneumovirus

Aizhan Esmagambetova, head of Kazakhstan's National Center for Public Health, has announced that there is no need for restrictive measures in response to identified cases of human metapneumovirus (HMPV) in the country. Human metapneumovirus is a respiratory tract infection that can cause inflammation in the upper and lower lungs. Although the virus has been circulating among humans since the mid-20th century, it has not previously caused widespread epidemics. Concerns about the virus were raised after foreign media reported an outbreak in neighboring China in late December 2024. The Chinese Center for Disease Control and Prevention confirmed the spread of acute respiratory infections, including HMPV, but Chinese authorities did not impose border closures similar to those during the COVID-19 pandemic in 2020. In Kazakhstan, the Ministry of Health reported detecting 30 cases of metapneumovirus between October 1, 2024, and early January 2025. The Committee of Sanitary and Epidemiological Control conducted testing on 8,360 non-influenza virus samples during the epidemic season, with 1,866 (22%) returning positive. Of these, metapneumovirus accounted for only 1.6%. Other respiratory infections were more prevalent, including: Rhinovirus: 680 cases (36.4%) Respiratory syncytial (RS) virus: 433 cases (23.2%) Adenovirus: 226 cases (12.1%) Coronavirus: 206 cases (11.1%) Parainfluenza: 178 cases (9.5%) Bocavirus: 113 cases (6.1%) The Ministry of Health stated that HMPV is primarily transmitted via airborne droplets and, to a lesser extent, through household contact. Despite this, Esmagambetova emphasized there is no justification for a quarantine:"The epidemiological situation in the country is stable. While we are in the midst of the epidemic season, a comparison of this year and last year shows a 20% decrease in acute respiratory viral infections (ARVI) for the same period," she explained. "As is typical, morbidity rises in January and declines by mid-February, but there are no grounds for quarantine or other restrictive measures. We are monitoring the epidemic situation, including morbidity and virus circulation, almost daily." Esmagambetova also highlighted that approximately 70% of cases in Kazakhstan occur in children under 14. She advised parents to keep children with signs of respiratory infections at home and avoid sending them to schools or kindergartens. She further recommended that citizens avoid crowded places, wear masks, and ensure proper ventilation. Kazakhstan’s Minister of Education, Gani Beisembayev, stated during a government meeting that the country’s education system is prepared to switch to distance learning if necessary. However, any decision to transition will depend on the Ministry of Health. This update comes after The Times of Central Asia reported outbreaks of seasonal and non-seasonal diseases across Central Asia last year, including influenza, measles, and hepatitis​.

Turkmenistan Strengthens Cooperation with IAEA to Equip New Cancer Center

Turkmenistan is deepening its collaboration with the International Atomic Energy Agency (IAEA) to advance nuclear medicine, as announced by Gurbanguly Berdimuhamedov, Chairman of the Halk Maslahaty (People's Council). The announcement came during his visit to the construction site of the new International Scientific and Clinical Center for Oncology in Ashgabat, as reported by the TDH news agency. Berdimuhamedov highlighted the importance of consulting with IAEA experts to ensure the center’s safe operation, particularly in handling radioactive waste. He stressed that equipping the facility with state-of-the-art technology is essential for meeting high standards in cancer treatment. The new center, under construction in the Choganly district in northern Ashgabat, will have a capacity of 500 beds. It will feature specialized departments for the diagnosis, treatment, and rehabilitation of cancer patients. Berdimuhamedov also emphasized the need to develop highly skilled medical personnel for the center. Medical professionals will be offered training opportunities in leading international clinics and encouraged to collaborate with foreign specialists. The facility aims to build strong partnerships with specialized medical institutions both within Turkmenistan and abroad. “International cooperation, particularly with the IAEA, is vital in the fight against cancer. Strengthening these ties is a key factor in the effective operation of the new center,” Berdimuhamedov stated. The oncology center is set to greatly enhance Turkmenistan’s healthcare system by providing advanced cancer care and contributing to global progress in nuclear medicine and cancer research.